Cargando…
Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo
Osteoporosis is characterized by a reduction of the bone mineral density (BMD) and microarchitectural deterioration of the bone, which lead to bone fragility and susceptibility to fracture. Astaxanthin (AST) has a variety of biological activities, such as a protective effect against asthma or neuroi...
Autores principales: | Hwang, Yun-Ho, Kim, Kwang-Jin, Kim, Su-Jin, Mun, Seul-Ki, Hong, Seong-Gyeol, Son, Young-Jin, Yee, Sung-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877773/ https://www.ncbi.nlm.nih.gov/pubmed/29562730 http://dx.doi.org/10.3390/ijms19030912 |
Ejemplares similares
-
The Protective Effects of Astaxanthin on the OVA-Induced Asthma Mice Model
por: Hwang, Yun-Ho, et al.
Publicado: (2017) -
In Vitro and In Vivo Effects of Gracilaria verrucosa Extracts on Osteoclast Differentiation
por: Kim, Kwang-Jin, et al.
Publicado: (2017) -
Protective Effects of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-d-glucoside on Ovariectomy Induced Osteoporosis Mouse Model
por: Kim, Su-Jin, et al.
Publicado: (2018) -
Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
por: Kim, Kwang-Jin, et al.
Publicado: (2018) -
Ethanol Extract of Atractylodes macrocephala Protects Bone Loss by Inhibiting Osteoclast Differentiation
por: Ha, Hyunil, et al.
Publicado: (2013)